TY - JOUR
T1 - Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
AU - Zlotoff, Daniel A.
AU - Hassan, Malek Z.O.
AU - Zafar, Amna
AU - Alvi, Raza M.
AU - Awadalla, Magid
AU - Mahmood, Syed S.
AU - Zhang, Lili
AU - Chen, Carol L.
AU - Ederhy, Stephane
AU - Barac, Ana
AU - Banerji, Dahlia
AU - Jones-O'connor, Maeve
AU - Murphy, Sean P.
AU - Armanious, Merna
AU - Forrestal, Brian J.
AU - Kirchberger, Michael C.
AU - Coelho-Filho, Otavio R.
AU - Rizvi, Muhammad A.
AU - Sahni, Gagan
AU - Mandawat, Anant
AU - Tocchetti, Carlo G.
AU - Hartmann, Sarah
AU - Gilman, Hannah K.
AU - Zatarain-Nicolás, Eduardo
AU - Mahmoudi, Michael
AU - Gupta, Dipti
AU - Sullivan, Ryan
AU - Ganatra, Sarju
AU - Yang, Eric H.
AU - Heinzerling, Lucie M.
AU - Thuny, Franck
AU - Zubiri, Leyre
AU - Reynolds, Kerry L.
AU - Cohen, Justine V.
AU - Lyon, Alexander R.
AU - Groarke, John
AU - Thavendiranathan, Paaladinesh
AU - Nohria, Anju
AU - Fradley, Michael G.
AU - Neilan, Tomas G.
N1 - Publisher Copyright:
© 2021 BMJ Publishing Group. All rights reserved.
PY - 2021/3/2
Y1 - 2021/3/2
N2 - Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other cardiac conditions; however, there are no data on their utility in ICI myocarditis. Methods From an international registry, ECG parameters were compared between 140 myocarditis cases and 179 controls across multiple time points (pre-ICI, on ICI prior to myocarditis, and at the time of myocarditis). The association between ECG values and major adverse cardiac events (MACE) was also tested. Results Both the QRS duration and QTc interval were similar between cases and controls prior to myocarditis. When compared with controls on an ICI (93±19 ms) or to baseline prior to myocarditis (97±19 ms), the QRS duration prolonged with myocarditis (110±22 ms, p<0.001 and p=0.009, respectively). In contrast, the QTc interval at the time of myocarditis (435±39 ms) was not increased compared with pre-myocarditis baseline (422±27 ms, p=0.42). A prolonged QRS duration conferred an increased risk of subsequent MACE (HR 3.28, 95% CI 1.98 to 5.62, p<0.001). After adjustment, each 10 ms increase in the QRS duration conferred a 1.3-fold increase in the odds of MACE (95% CI 1.07 to 1.61, p=0.011). Conversely, there was no association between the QTc interval and MACE among men (HR 1.33, 95% CI 0.70 to 2.53, p=0.38) or women (HR 1.48, 95% CI 0.61 to 3.58, p=0.39). Conclusions The QRS duration is increased in ICI myocarditis and is associated with increased MACE risk. Use of this widely available ECG parameter may aid in ICI myocarditis diagnosis and risk-stratification.
AB - Background Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other cardiac conditions; however, there are no data on their utility in ICI myocarditis. Methods From an international registry, ECG parameters were compared between 140 myocarditis cases and 179 controls across multiple time points (pre-ICI, on ICI prior to myocarditis, and at the time of myocarditis). The association between ECG values and major adverse cardiac events (MACE) was also tested. Results Both the QRS duration and QTc interval were similar between cases and controls prior to myocarditis. When compared with controls on an ICI (93±19 ms) or to baseline prior to myocarditis (97±19 ms), the QRS duration prolonged with myocarditis (110±22 ms, p<0.001 and p=0.009, respectively). In contrast, the QTc interval at the time of myocarditis (435±39 ms) was not increased compared with pre-myocarditis baseline (422±27 ms, p=0.42). A prolonged QRS duration conferred an increased risk of subsequent MACE (HR 3.28, 95% CI 1.98 to 5.62, p<0.001). After adjustment, each 10 ms increase in the QRS duration conferred a 1.3-fold increase in the odds of MACE (95% CI 1.07 to 1.61, p=0.011). Conversely, there was no association between the QTc interval and MACE among men (HR 1.33, 95% CI 0.70 to 2.53, p=0.38) or women (HR 1.48, 95% CI 0.61 to 3.58, p=0.39). Conclusions The QRS duration is increased in ICI myocarditis and is associated with increased MACE risk. Use of this widely available ECG parameter may aid in ICI myocarditis diagnosis and risk-stratification.
KW - autoimmunity
KW - immune tolerance
KW - immunotherapy
KW - inflammation
KW - self tolerance
UR - http://www.scopus.com/inward/record.url?scp=85102123979&partnerID=8YFLogxK
U2 - 10.1136/jitc-2020-002007
DO - 10.1136/jitc-2020-002007
M3 - Article
C2 - 33653803
AN - SCOPUS:85102123979
SN - 2051-1426
VL - 9
JO - Journal for ImmunoTherapy of Cancer
JF - Journal for ImmunoTherapy of Cancer
IS - 3
M1 - e002007
ER -